BUYINS.NET Updates OxySure Therapeutics (OXYS) SqueezeTrigger Report
· Approximately 16.75 Million Shares Shorted Since June 2012 · Short Squeeze Expected When Stock Crosses Above $0.47 SqueezeTrigger PriceFRISCO, TX--(Marketwired - March 14, 2016) - OxySure Therapeutics, Inc. (OXYS ) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions today announced BUYINS.NET, http://